CRVO CERVOMED INC revenue, earnings and financials
For the quarter ended June 30, 2026, CERVOMED INC reported revenue of $0 (down 100.0% from a year earlier), net income of −$6.57M and diluted EPS of n/a; over the last four quarters revenue was $331K and net income −$30.4M; for the fiscal year ended December 2025 revenue was $4.01M, down 58.9% on the year before.
CRVO annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $4.01M, gross profit n/a, operating income −$28.3M, net income −$27.0M (margin -673.2%), EPS n/a
- Fiscal year ended Dec 2024: revenue $9.74M, gross profit n/a, operating income −$18.2M, net income −$16.3M (margin -167.3%), EPS n/a
- Fiscal year ended Dec 2023: revenue $7.14M, gross profit n/a, operating income −$7.81M, net income −$2.17M (margin -30.4%), EPS n/a
- Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$3.48M, net income −$5.80M (margin n/a), EPS $2038891.00
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$24.7M, net income −$24.1M (margin n/a), EPS $1946859.00
CRVO quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0 (down 100.0% year over year), net income −$6.57M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $0 (down 100.0% year over year), net income −$7.96M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $8.73K (down 99.6% year over year), net income −$8.09M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $323K (down 83.4% year over year), net income −$7.73M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $1.76M (down 46.6% year over year), net income −$6.26M, EPS n/a
- Quarter ended Mar 31, 2025: revenue $1.92M (down 18.3% year over year), net income −$4.89M, EPS n/a
- Quarter ended Dec 31, 2024 (from the annual report): revenue $2.16M (down 13.2% year over year), net income −$6.71M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $1.94M (up 27.1% year over year), net income −$4.75M, EPS −$0.55
- Quarter ended Jun 30, 2024: revenue $3.29M (up 91.2% year over year), net income −$2.32M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $2.35M (up 66.7% year over year), net income −$2.51M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $2.49M, net income −$2.36M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $1.53M, net income $2.15M, EPS −$0.70
- Quarter ended Jun 30, 2023: revenue $1.72M, net income −$1.43M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $1.41M, net income −$534K, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income $3.80M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $0, net income −$883K, EPS −$1.70
- Quarter ended Jun 30, 2022: revenue n/a, net income −$4.19M, EPS n/a
- Quarter ended Mar 31, 2022: revenue n/a, net income −$4.53M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$3.47M, EPS −$285281283.00
- Quarter ended Sep 30, 2021: revenue n/a, net income −$12.2M, EPS $101903979.00
CRVO cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$23.4M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$16.5M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$7.45M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$2.57M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$14.5M, share buybacks n/a
CRVO balance sheet
- Jun 30, 2026: cash $22.5M, total assets $26.0M, total liabilities $3.03M, shareholders' equity $23.0M
- Mar 31, 2026: cash $7.94M, total assets $15.1M, total liabilities $4.50M, shareholders' equity $10.6M
- Dec 31, 2025: cash $8.24M, total assets $22.9M, total liabilities $4.66M, shareholders' equity $18.2M
- Sep 30, 2025: cash $9.44M, total assets $30.6M, total liabilities $4.60M, shareholders' equity $26.0M
- Jun 30, 2025: cash $8.32M, total assets $38.1M, total liabilities $4.64M, shareholders' equity $33.4M
- Mar 31, 2025: cash $10.5M, total assets $38.6M, total liabilities $3.94M, shareholders' equity $34.6M
- Dec 31, 2024: cash $9.00M, total assets $43.1M, total liabilities $3.88M, shareholders' equity $39.2M
- Sep 30, 2024: cash $7.74M, total assets $48.9M, total liabilities $3.25M, shareholders' equity $45.6M
What is CRVO's revenue?
CERVOMED INC reported $331K of revenue over its last four quarters, through June 30, 2026.
Is CRVO profitable?
No. CERVOMED INC lost $30.4M over the last four quarters.